Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

Michael R. Bristow, Robert Ginsburg, Wayne Minobe, Roger S. Cubicciotti, W. Scott Sageman, Keith Lurie, Margaret E. Billingham, Donald C. Harrison, Edward B. Stinson

Research output: Contribution to journalArticlepeer-review

1831 Scopus citations


To identify the role of the myocardial β-adrenergic pathway in congestive heart failure, we examined β-adrenergic-receptor density, adenylate cyclase and creatine kinase activities, muscle contraction in vitro, and myocardial contractile protein levels in the left ventricles of failing and normally functioning hearts from cardiac-transplant recipients or prospective donors. Eleven failing left ventricles had a 50 to 56 per cent reduction in β-receptor density, a 45 per cent reduction in maximal isoproterenol-mediated adenylate cyclase stimulation, and a 54 to 73 per cent reduction in maximal isoproterenol-stimulated muscle contraction, as compared with six normally functioning ventricles (P<0.05 for each comparison). In contrast, cytoplasmic creatine kinase activity, adenylate cyclase activities stimulated by fluoride ion and by histamine, histamine-stimulated muscle contraction, and levels of contractile protein were not different in the two groups (P>0.05). We conclude that in failing human hearts a decrease in β-receptor density leads to subsensitivity of the β-adrenergic pathway and decreased β-agonist-stimulated muscle contraction. Regulation of β-adrenergic receptors may be an important variable in cardiac failure. (N Engl J Med. 1982; 307:205–11.) THE hallmark of congestive heart failure is decreased myocardial inotropic function. Although previous studies in animal models and human tissue have documented a variety of biochemical changes associated with heart failure,1,2 none of these changes appears to be adequate to explain the marked decrease in contractile function that occurs in advanced heart-muscle disease. Perhaps the most likely location for a primary abnormality in cardiac failure is in the specialized cellular components that modulate calcium flux,3 some of which reside in the sarcolemma. One component of this system is the β-adrenergic receptor; through combination with a hormone agonist, this receptor may.

Original languageEnglish (US)
Pages (from-to)205-211
Number of pages7
JournalNew England Journal of Medicine
Issue number4
StatePublished - Jul 22 1982


Dive into the research topics of 'Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts'. Together they form a unique fingerprint.

Cite this